Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

T Cell Sciences, Astra negotiating collaboration on multiple sclerosis therapy.

Executive Summary

T CELL, ASTRA NEGOTIATING COLLABORATION ON MS THERAPY using "a humanized monoclonal antibody and a peptide that inhibit a specific subset of T cells related to the autoimmune disease multiple sclerosis," T Cell Sciences reports in a preliminary prospectus for a public offering. T Cell identified the compounds "in conjunction with Astra." Internal funding of the research has been halted pending outcome of the negotiations.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel